[go: up one dir, main page]

MX174161B - Una forma de dosis para suministrar el farmaco benefico verapamil - Google Patents

Una forma de dosis para suministrar el farmaco benefico verapamil

Info

Publication number
MX174161B
MX174161B MX9203557A MX9203557A MX174161B MX 174161 B MX174161 B MX 174161B MX 9203557 A MX9203557 A MX 9203557A MX 9203557 A MX9203557 A MX 9203557A MX 174161 B MX174161 B MX 174161B
Authority
MX
Mexico
Prior art keywords
verapamil
dosage form
pharmacy
beneficial
supply
Prior art date
Application number
MX9203557A
Other languages
English (en)
Other versions
MX9203557A (es
Inventor
Sally I Stephens
L G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9203557A publication Critical patent/MX9203557A/es
Publication of MX174161B publication Critical patent/MX174161B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX9203557A 1986-03-19 1992-06-26 Una forma de dosis para suministrar el farmaco benefico verapamil MX174161B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/841,144 US4753802A (en) 1986-03-19 1986-03-19 Verapamil dosage form

Publications (2)

Publication Number Publication Date
MX9203557A MX9203557A (es) 1992-09-01
MX174161B true MX174161B (es) 1994-04-25

Family

ID=25284138

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203557A MX174161B (es) 1986-03-19 1992-06-26 Una forma de dosis para suministrar el farmaco benefico verapamil

Country Status (12)

Country Link
US (1) US4753802A (es)
EP (1) EP0238189B1 (es)
JP (1) JPH0798748B2 (es)
KR (1) KR900003385B1 (es)
AT (1) ATE59549T1 (es)
AU (1) AU587307B2 (es)
CA (1) CA1261703A (es)
DE (1) DE3766858D1 (es)
ES (1) ES2019632B3 (es)
GR (1) GR3001290T3 (es)
MX (1) MX174161B (es)
ZA (1) ZA871031B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
EP0455648B1 (en) * 1989-01-30 1993-03-10 Alza Corporation Dosage form for administering calcium antagonist
HU205851B (en) * 1989-01-31 1992-07-28 Int Pharma Agentur Systhem of regulated release of the active components and process for producing it
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5364635A (en) * 1989-09-28 1994-11-15 Knoll Ag Solid drug form with a high verapamil content
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
US8734850B2 (en) 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
DE102005031868A1 (de) * 2005-07-04 2007-01-18 Biotronik Vi Patent Ag Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
AU2011230778A1 (en) * 2010-03-23 2012-08-02 Aska Pharmaceutical Co., Ltd. Solid preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
CA1266827A (en) * 1984-06-20 1990-03-20 Merck & Co., Inc. Controlled porosity osmotic pump

Also Published As

Publication number Publication date
CA1261703A (en) 1989-09-26
AU587307B2 (en) 1989-08-10
MX9203557A (es) 1992-09-01
US4753802A (en) 1988-06-28
DE3766858D1 (de) 1991-02-07
GR3001290T3 (en) 1992-08-26
EP0238189A1 (en) 1987-09-23
ZA871031B (en) 1987-08-04
AU6871587A (en) 1987-09-24
KR900003385B1 (ko) 1990-05-18
ES2019632B3 (es) 1991-07-01
JPS62226924A (ja) 1987-10-05
JPH0798748B2 (ja) 1995-10-25
ATE59549T1 (de) 1991-01-15
EP0238189B1 (en) 1991-01-02
KR870008594A (ko) 1987-10-19

Similar Documents

Publication Publication Date Title
MX9203557A (es) Una forma de dosis para suministrar el farmaco benefico verapamil.
DE3688532D1 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
ES2159184T3 (es) Nueva posologia para la dmni.
AR210273A1 (es) Conduccion implantable en el cuerpo
AR240399A1 (es) Dispositivo suministrador para administrar una formulacion de agente beneficioso a un ambiente de uso.
MX158797A (es) Mejoras a composicion limpiadora y desodorante para el cuerpo
ES2052066T3 (es) Mejoras en o relacionadas con compuestos organicos.
ES550728A0 (es) Perfeccionamientos en un cuerpo acolchado para el habitaculode los automoviles
MX9204560A (es) Mejoras en un cuerpo filtrante y procedimiento para fabricar el mismo.
NL193440B (nl) Farmaceutisch preparaat met analgetische werking.
MX9202663A (es) Composicion para refrescar el aire.
MX174157B (es) Forma de dosis para suministrar diltiazen
ES508802A0 (es) Prodedimiento y maqina para compactar el lecho de labastro de una via a corregir.
NO862870D0 (no) Overfoering av fluidium i aapen sjoe.
MX9200431A (es) Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.
ES2024019B3 (es) Dispositivo para comprobar el grosor de las hojas de impresion en una impresora.
ES262011Y (es) Dispositivo de flotacion para soportar a una persona en el agua.
MX9203782A (es) Forma de dosis con capacidad de administracion mejorada.
ES200862Y (es) Una unidad de defensa desviable, adecuada para el uso en una estructura de mueble.
FI821324A0 (fi) Oxazolderivat
DE3879641D1 (de) Statischer ausloeser mit externer versorgung.
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
ES1002588Y (es) Zapato deportivo, en particular para el baloncesto
USD224049S (en) Printed circuit holding jig